In conclusion, our studies showed that anti-pneumococcal vaccination with Prevnar-13 associates with amelioration of disease severity in murine lupus, a phenomenon associated with reduced TNF-α and IL-6 production by B cells and increased TFR/TFH ratio. This evidence concerns the gene IL6 and systemic lupus erythematosus.